WebApr 6, 2024 · According to 12 analysts, the average rating for IMUX stock is "Buy." The 12-month stock price forecast is $19.38, which is an increase of 1,209.46% from the latest … WebImmunic, Inc (NASDAQ: IMUX) reported data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset, vidofludimus calcium (IMU-838), in patients with moderate … Find the latest Immunic, Inc. (IMUX) stock discussion in Yahoo Finance's forum. … Discover historical prices for IMUX stock on Yahoo Finance. View daily, weekly or … Find out all the key statistics for Immunic, Inc. (IMUX), including valuation … Find out the direct holders, institutional holders and mutual fund holders for … See Immunic, Inc. (IMUX) Environment, Social and Governance Ratings to help … See Immunic, Inc. (IMUX) stock analyst estimates, including earnings and … Immunic (IMUX) reports positive results from the maintenance phase of the … Get the detailed quarterly/annual income statement for Immunic, Inc. (IMUX). Find … Find the latest Immunic, Inc. (IMUX) stock quote, history, news and other vital … Find the latest Immunic, Inc. (IMUX) stock quote, history, news and other vital …
IMUX Immunic Inc. SEC Filings MarketWatch
WebImmunic AG was founded in 2016 with headquarters in Planegg-Martinsried, Germany. Since April 2024, the company has been operating under the name Immunic, Inc. with its … WebFeb 24, 2024 · NEW YORK, February 24, 2024 – Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced financial results for the fourth quarter and year ended December 31, 2024 and … data analytics course in pune
Immunic, Inc. InvestorRoom - Stock Quote
WebIMUX: Immunic Inc - Stock Price, Quote and News - CNBC Immunic Inc IMUX:NASDAQ EXPORT WATCHLIST + LIVE SHARK TANK RT Quote Last NYSE Arca, VOL From CTA … WebApr 11, 2024 · Immunic - IMUX - Stock Price Today - Zacks Immunic (IMUX) (Delayed Data from NSDQ) $1.44 USD +0.11 (8.27%) Updated Apr 11, 2024 04:00 PM ET After-Market: … WebMay 5, 2024 · Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases ... bitiba telephone number